Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions

Into the Eye of the Cytokine Storm

Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940

Is a “Cytokine Storm” Relevant to COVID-19?

Sinha, P., Matthay, M. A., & Calfee, C. S. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.3313 · Cited by 724

Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers

Khan, S. S., Smith, M. S., Reda, D., Suffredini, A. F., & McCoy, J. P. (2004) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20021 · Cited by 357

Cytometry

Özgen, Ü., Savaşan, S., Buck, S. A., & Ravindranath, Y. (2010) · Cytometry · doi:10.1002/(issn)1097-0320 · Cited by 211

Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients

Timmermans, K., Kox, M., Vaneker, M., van den Berg, M. P., John, A. T., van Laarhoven, A., van der Hoeven, H., Scheffer, G. J., & Pickkers, P. (2016) · Intensive Care Medicine · doi:10.1007/s00134-015-4205-3 · Cited by 184

Norepinephrine Contributes to Enterocyte Damage in Septic Shock Patients: A Prospective Cohort Study

Habes, Q. L. M., van Ede, L., Gerretsen, J., Kox, M., & Pickkers, P. (2017) · Shock · doi:10.1097/shk.0000000000000955 · Cited by 31

The Involvement of Danger-Associated Molecular Patterns in the Development of Immunoparalysis in Cardiac Arrest Patients

Timmermans, K., Kox, M., Gerretsen, J., Peters, E., Scheffer, G. J., van der Hoeven, J. G., Pickkers, P., & Hoedemaekers, C. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001204 · Cited by 30

Pathogenesis of the initial stages of severe COVID-19

Голота, А. С., Kamilova, Т. A., Shneider, O. V., Vologzhanin, D. A., & Sherbak, S. G. (2021) · Journal of clinical practice · doi:10.17816/clinpract71351 · Cited by 7

Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

Mert, A., Vahaboğlu, H., Arslan, F., Batırel, A. A., Saraçoğlu, K. T., Baştuğ, A., Çağatay, A., Irmak, İ., Dizman, G. T., Ertenli, İ., et al. (2021) · Rheumatology International · doi:10.1007/s00296-021-04965-6 · Cited by 7

Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective

Kilcoyne, A., Jordan, E., Zhou, A., Thomas, K., Pepper, A. N., Chappell, D. B., Amarapala, M., Hughes, A., & Thompson, M. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2030148 · Cited by 7

Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy

Lebedeva, А., Molodtsov, I. A., Anisimova, A., Berestovskaya, A., Dukhin, O., Elizarova, A., Fitzgerald, W., Fomina, D. S., Glebova, K. A., Ivanova, O., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147937 · Cited by 8

Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19

Pearson, M. M., Limaye, A. P., & Biggins, S. W. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.12.050 · Cited by 8

Evaluating the evidence for GM-CSF as a host-directed therapy in respiratory infections

David, C., Verney, C., Si‐Tahar, M., & Guillon, A. (2025) · Cytokine · doi:10.1016/j.cyto.2025.156902 · Cited by 7

Effect of decreasing respiratory rate on the mechanical power of ventilation and lung injury biomarkers: a randomized cross-over clinical study in COVID-19 ARDS patients

Damiani, L. F., Basoalto, R., Oviedo, V., Alegría, L., Soto, D., Bachmann, M. C., Jalil, Y., Santis, C., Carpio, D., Ulloa, R., et al. (2025) · Intensive Care Medicine Experimental · doi:10.1186/s40635-025-00782-4 · Cited by 6

Efficacy and Safety of Mesenchymal Stromal Cells Therapy for COVID-19 Infection: A Systematic Review and Meta-analysis

Li, Y., Wei, Z., Ma, X., Xu, J., Zhao, X., Cao, Q., & Di, G. (2021) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x16666211206145839 · Cited by 6

Interleukin-6-Production Is Responsible for Induction of Hepatic Synthesis of Several Chemokines as Acute-Phase Mediators in Two Animal Models: Possible Significance for Interpretation of Laboratory Changes in Severely Ill Patients

Malik, I. A., & Ramadori, G. P. (2022) · Biology · doi:10.3390/biology11030470 · Cited by 6

Exploring heterogeneity in reported venous thromboembolism risk in COVID-19 and comparison to other viral pneumonias: a systematic review and meta-regression

Bhoelan, S., Codreanu, C., Tichelaar, V., Howard, J. B., & Meijer, K. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.102146 · Cited by 6

Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National Cohort

Oblitas, C., Rodríguez, P. D., Álvarez-Sala, J. L., Rubio‐Rivas, M., Navarro-Romero, F., Galvañ, V. G., Huerta, L. D. J., Aizpuru, E. F., García, G. M. G., Pérez, J. L. B., et al. (2024) · Viruses · doi:10.3390/v16030335 · Cited by 6

Early management of critically ill patients with COVID‐19

Gutiérrez‐Zarate, D., Rosas-Sánchez, K., Flores-Carrillo, J. C., Medrano-Ahumada, S., & Martínez‐Franco, M. (2020) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12294 · Cited by 6

GM-CSF Promotes Immune Response and Survival in a Mouse Model of COVID-19Preprint

Kendall, L. V., Boyd, T. D., Sillau, S., Bosco‐Lauth, A. M., Markham, N. E., Fong, D. L., Clarke, P., Tyler, K. L., & Potter, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1213395/v1 · Cited by 6

Cytokine and Chemokine Levels in COVID-19 Convalescent Plasma

Bonny, T. S., Patel, E. U., Zhu, X., Grabowski, M., Littlefield, K. E., Laeyendecker, O. B., Casadevall, A., & Tobian, A. A. R. (2020) · Open Forum Infectious Diseases · Cited by 5

Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19

Kruglova, T. S., Fomina, D. S., Потешкина, Н. Г., Frolova, N. F., Павловна, Б. И., Mutovina, Z. Y., Samsonova, I. V., Kovalevskaja, E. A., Игоревна, З. А., Serdotetskova, S. A., et al. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.11.201248 · Cited by 5

Dietary supplements and nutraceuticals in the recovery of COVID-19: A systematic review and meta-analysis

Aldhafiri, F. K. (2022) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2022.07.001 · Cited by 5

Subphenotypes of SARS-CoV-2-Associated ARDS Overlap Each Other: A Retrospective Analysis

Nair, P. R., Girish, K., Mini, G., Khan, T., Haritha, D., Sanyal, K., Bhattacharjee, S., Baidya, D. K., Ray, B. R., Anand, R. K., et al. (2023) · Journal of Laboratory Physicians · doi:10.1055/s-0043-1768952 · Cited by 5

A real‐world study of glucocorticoid treatment in COVID‐19 patients with different disease severities

Jiao, X., Ya, W., Liu, D., Zeng, S., Chi, J., Li, R., Yang, Y. P., Yu, R., Wang, S., Yuan, Y., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.235 · Cited by 5

Absence of “Cytokine Storm” in Hospitalized COVID-19 Patients: A Retrospective Cohort Study

Ciampa, M. L., O’Hara, T. A., Joel, C. L., Gleaton, M., Tiwari, K. K., Boudreaux, D. M., & Prasad, B. M. (2021) · Infectious Disease Reports · doi:10.3390/idr13020036 · Cited by 7

Metabolic characteristics in patients with COVID-19 and no-COVID-19 interstitial pneumonia with mild-to-moderate symptoms and similar radiological severity

Rizza, S., Nucera, A., Chiocchi, M., Bellia, A., Mereu, D., Ferrazza, G., Ballanti, M., Davato, F., Cola, G. D., Buonomo, C. O., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.08.035 · Cited by 5

Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England

Kilcoyne, A., Jordan, E., Thomas, K., Pepper, A. N., Zhou, A., Chappell, D. B., Amarapala, M., Thériault, R.-K., & Thompson, M. (2022) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s360741 · Cited by 5

Extracorporeal Cytokine Removal in Critically Ill COVID-19 Patients: A Case Series

Virág, M., Rottler, M., Ocskay, K., Leiner, T., Horváth, B., Adam, D., Vasquez, A., Bucsi, L., Sárkány, Á., & Molnár, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.760435 · Cited by 4

Immune Response to SARS-CoV-2 Vaccine among Heart Transplant Recipients: A Systematic Review

Shoar, S., Prada-Ruiz, A. C., Patarroyo‐Aponte, G., Chaudhary, A., & Asadi, M. S. (2022) · Clinical Medicine Insights Circulatory Respiratory and Pulmonary Medicine · doi:10.1177/11795484221105327 · Cited by 4

Transpulmonary Plasma Endothelin-1 Arterial:Venous Ratio Differentiates Survivors from Non-Survivors in Critically Ill Patients with COVID-19-Induced Acute Respiratory Distress Syndrome

Vassiliou, A. G., Roumpaki, A., Keskinidou, C., Athanasiou, N., Tsipilis, S., Jahaj, E., Vrettou, C. S., Giannopoulou, V., Halioti, A., Ferentinos, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910640 · Cited by 4

Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19

Vassiliou, A. G., Dimopoulou, I., Jahaj, E., Keskinidou, C., Mastora, Z., Orfanos, S. E., & Kotanidou, Α. (2021) · In Vivo · doi:10.21873/invivo.12381 · Cited by 4

Tailored modulation of the inflammatory balance in COVID-19 patients admitted to the ICU?—a viewpoint

Kuindersma, M., Diaz, R. R., & Spronk, P. E. (2021) · Critical Care · doi:10.1186/s13054-021-03607-4 · Cited by 4

IMPACT OF ANTIDIABETIC DRUGS ON RISK AND OUTCOME OF COVID-19 INFECTION: A REVIEW

Zainal, A. A., & Merkhan, M. M. (2022) · Military Medical Science Letters · doi:10.31482/mmsl.2022.004 · Cited by 6

Mapping global trends in research of stem cell therapy for COVID-19: A bibliometric analysis

Zhang, X., Cai, J., Chen, L., Yang, Q., Tian, H., Wu, J., Ji, Z., Zheng, D., Li, Z., & Chen, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1016237 · Cited by 4

Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study

Lamouche-Wilquin, P., Perrin, L., Péré, M., Raymond, M., Asfar, P., Darreau, C., Reizine, F., Colin, G., Delbove, A., Auchabie, J., et al. (2023) · Thrombosis Journal · doi:10.1186/s12959-023-00491-6 · Cited by 4

Multi-faceted dysregulated immune response for COVID-19 infection explaining clinical heterogeneity

Paine, S. K., Choudhury, P., Alam, M., Bhattacharyya, C., Pramanik, S., Tripathi, D., Das, C., Patel, V., Ghosh, S., Chatterjee, S., et al. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156434 · Cited by 4

COVID-19 and the role of stem cells

Alanazi, A. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.08.008 · Cited by 4

Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma

Fanning, S. L., Korngold, R., Yang, Z. R., Goldgirsh, K., Park, S., Zenreich, J., Baker, M., McKiernan, P., Tan, M. T., Zhang, B., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010025 · Cited by 4

Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England

Kilcoyne, A., Jordan, E., Thomas, K., Pepper, A. N., Zhou, A., Chappell, D. B., Amarapala, M., Thériault, R.-K., & Thompson, M. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4

Large-scale single-cell analysis reveals critical immune characteristics of COVID-19 patientsPreprint

Ren, X., Wen, W., Fan, X., Hou, W., Su, B., Cai, P., Li, J., Liu, Y., Tang, F., Zhang, F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.29.360479 · Cited by 4

Specific and Non-specific Aspects and Future Challenges of ICU Care Among COVID-19 Patients with Obesity: A Narrative Review

Beurton, A., Kooistra, E. J., JONG, A. D., Schiffl, H., Jourdain, M., Garcia, B., Vimpère, D., Jaber, S., Pickkers, P., & Papazian, L. (2024) · Current Obesity Reports · doi:10.1007/s13679-024-00562-3 · Cited by 3

Critical risks of haemoadsorption for COVID-19 patients and directions for future evaluations: a nationwide propensity score matched cohort study

Kloka, J. A., Jasny, T., Old, O., Nürenberg‐Goloub, E., Scharf, C., Meybohm, P., Supady, A., Zacharowski, K. D., & Friedrichson, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-13860-0 · Cited by 3

Clinical Features of COVID-19 and Differentiation from Other Causes of CAP

Gao, C. A., Pickens, C. I., Morales‐Nebreda, L., & Wunderink, R. G. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1759889 · Cited by 4

Inflammation and Venous Thromboembolism in Hospitalized Patients with COVID-19

Liontos, A., Biros, D., Matzaras, R., Tsarapatsani, K.-H., Kolios, N.-G., Zarachi, A., Tatsis, K., Pappa, C., Nasiou, M., Pargana, E., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13223477 · Cited by 3

Biomarker Analysis Provides Evidence for Host Response Homogeneity in Patients With COVID-19

van Amstel, R. B. E., Michels, E. H. A., Appelman, B., de Brabander, J., Smeele, P. J., van der Poll, T., Vlaar, A. P. J., van Vught, L. A., Bos, L. D. J., van Agtmael, M. A., et al. (2024) · CHEST Critical Care · doi:10.1016/j.chstcc.2024.100062 · Cited by 3

Case study observational research: inflammatory cytokines in the bronchial epithelial lining fluid of COVID-19 patients with acute hypoxemic respiratory failure

Sudo, K., Kinoshita, M., Kawaguchi, K., Kushimoto, K., Yoshii, R., Inoue, K., Yamasaki, M., Matsuyama, T., Kooguchi, K., Takashima, Y., et al. (2024) · Critical Care · doi:10.1186/s13054-024-04921-3 · Cited by 3

Quantitative Evaluation of Microcirculatory Alterations in Patients with COVID-19 and Bacterial Septic Shock through Remote Photoplethysmography and Automated Capillary Refill Time Analysis

Klibus, M., Smirnova, D., Marcinkevičs, Z., Rubīns, U., Grabovskis, A., Vanags, I., & Sabeļņikovs, O. (2024) · Medicina · doi:10.3390/medicina60101680 · Cited by 3

Clinical and Laboratory Outcomes of the Solid Cancer Patients Reinfected with SARS-CoV-2

Ünsal, O., Yazıcı, O., Özdemir, N., Çubukçu, E., Ocak, B., Üner, A., & Özet, A. (2021) · Future Oncology · doi:10.2217/fon-2021-0621 · Cited by 3

NET-Mediated Pathogenesis of COVID-19: The Role of NETs in Hepatic Manifestations

Al-Kattan, W., Yaqinuddin, A., Shafqat, A., & Kashir, J. (2022) · Journal of Health and Allied Sciences NU · doi:10.1055/s-0041-1741418 · Cited by 3

SARS-CoV-2-Infection (COVID-19): Clinical Course and Cause(s) of DeathPreprint

Ramadori, G. P. (2022) · Preprints.org · doi:10.20944/preprints202204.0118.v1 · Cited by 3

Systemic Inflammation Alters The Neuroinflammatory Response: A Prospective Clinical Trial In Traumatic Brain InjuryPreprint

Lassarén, P., Lindblad, C., Frostell, A., Carpenter, K. L. H., Guilfoyle, M. R., Hutchinson, P., Helmy, A. E., & Thelin, E. P. (2021) · Research Square · doi:10.21203/rs.3.rs-345717/v2 · Cited by 3

Kidney Issues Associated with COVID-19 Disease

Dousdampanis, P., Mouzaki, Α., Trigka, K., Stefanidis, I., Galanopoulos, K.-E., Siavelis, I.-S., Stathopoulou, D., & Assimakopoulos, S. F. (2023) · Encyclopedia · doi:10.3390/encyclopedia3030079 · Cited by 3

Differences in the Phenotype of Bacterial and Viral Sepsis—A Prospective, Multicenter, Observational Study

Perschinka, F., Lehner, G. F., Mayerhöfer, T., Köhler, A., Hasibeder, W. R., Krismer, C., Killian, J., Fries, D. R., Bösch, J., Perschinka, N., et al. (2025) · Viruses · doi:10.3390/v17121617 · Cited by 3

"Prevention and Treatment of Acute Respiratory Distress Syndrome by COVID-19: Role of Vitamin D on Immunomodulation and Renin-Angiotensin- Aldosterone System Regulation"

Jahangiria, M. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.39.006314 · Cited by 2

Polyunsaturated Fatty Acid-Derived Lipid Mediators as Biomarkers in Critical Care

Khan, B., O’Laughlin, A., Perelas, A., Thatcher, T. H., & Jackson, P. (2023) · Biomarkers in disease · doi:10.1007/978-3-031-07395-3_77 · Cited by 1

Assessment of interleukin-6 role in detecting coronavirus disease 2019 severity, mortality, and its control

Shalaby, H. M., Elmaksoud, S. S. A., Ezzelregal, H. G., & Salem, D. D. E. (2023) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.4103/ecdt.ecdt_75_22 · Cited by 2

Multifaceted roles of Fcγ receptors in COVID-19 and vaccine responses.

Bouayad, A. (2023) · PubMed Central · Cited by 2

Soporte ventilatorio en pacientes críticos con COVID-19:a 18 meses de la pandemia en Chile

Ulloa, R., Born, P., Kattan, E., & Bugedo, G. J. (2021) · Revista Chilena de Anestesia · doi:10.25237/revchilanestv5001101606 · Cited by 2

Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection

May, M. R., Rübben, A., Lennertz, A., Vanstreels, L., & Leijs, M. M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020173 · Cited by 2

Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia

Franchini, S., Mette, F., Landoni, G., Setti, E., Ferrante, L., Calcaterra, B., Pagliula, G., Barbieri, A., FONTANI, D., Borio, G., et al. (2022) · Panminerva Medica · doi:10.23736/s0031-0808.22.04562-1 · Cited by 2

Anakinra for patients with COVID-19: an updated systematic review and meta-analysis

Cavalli, G., Navalesi, P., Landoni, G., Yavorovskiy, A. G., Likhvantsev, V. V., Zangrillo, A., Dagna, L., Monti, G., & Pasin, L. (2023) · Signa Vitae · doi:10.22514/sv.2023.025 · Cited by 2

Predicting outcomes in COVID-19: From internal validation to improving care

Taseen, R., & Cantin, A. M. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103090 · Cited by 2

Severe Acute Respiratory Syndrome Coronavirus 2: Manifestations of Disease and Approaches to Treatment and Prevention in Humans

Watson, M. E., Inagaki, K., & Weinberg, J. B. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-21-000011 · Cited by 3

IRE1α-XBP1 Activation Elicited by Viral Singled Stranded RNA via TLR8 May Modulate Lung Cytokine Induction in SARS-CoV-2 PneumoniaPreprint

Fernández, J. J., Mancebo, C., Garcinuño, S., March, G., Alvarez, Y., Alonso, S., Inglada, L., Blanco, J., Orduña, A., Montero, O., et al. (2022) · medRxiv · doi:10.1101/2022.01.26.22269752 · Cited by 1

The IRE1-XBP1 Branch of the Unfolded Protein Response Underpins Cytokine Induction and Viral Replication in SARS-CoV-2 Infection

Rodríguez, J. J. F. (2023) · doi:10.35376/10324/61445 · Cited by 2

Transpulmonary Plasma Endothelin-1 Arterial:Venous Ratio Differentiates Survivors from Non-Survivors in Critically Ill Patients with COVID-19-Induced ARDSPreprint

Vassiliou, A. G., Roumpaki, A., Keskinidou, C., Athanasiou, N., Tsipilis, S., Jahaj, E., Vrettou, C. S., Giannopoulou, V., Halioti, A., Ferentinos, G., et al. (2024) · Preprints.org · doi:10.20944/preprints202408.0696.v1 · Cited by 2

IL-1β-driven NF-κB transcription of ACE2 as a Mechanism of Macrophage Infection by SARS-CoV-2Preprint

Lee, C. F., Khan, R., Mantsounga, C., Sharma, S., Pierce, J., Amelotte, E., Butler, C. A., Farinha, A., Parry, C., Caballero, O., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.24.630260 · Cited by 2

Role of InterLeukin-6 monitoring during weaning from volume-controlled ventilation in patients with COVID-19 acute respiratory distress syndrome

Delaunay, E., Poussard, N., Gourjon, G., Frouin, A., Ducq, P., Vico, L., Moschietto, S., Larcher, R., & Pradel, G. (2025) · Science Progress · doi:10.1177/00368504251335850 · Cited by 1

Decoding Immune Dysregulation in Sepsis Through Extracellular Vesicles: A Path to Precision Medicine

Schiavello, M., Vizio, B., Bosco, O., Dini, C., Pivetta, E., Morello, F., & Lupia, E. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18050570 · Cited by 1

BIOMARKERS IN THE ACUTE RESPIRATORY DISTRESS SYNDROME: PAST, PRESENT, AND FUTURE.

Parsons, P. E. (2022) · PubMed Central · Cited by 1

Repurposing an ‘Old’ Drug for the Treatment of COVID-19-Related Cytokine Storm

Pontali, E., & Filauro, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103386 · Cited by 1

Association Between Selective Serotonin Reuptake Inhibitors Prevalent Use and COVID-19–Related Mortality

Osores, P. I., Vivacqua, M. N., Vázquez, C., Marciano, S., Giunta, D. H., & Faccioli, J. L. (2023) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001721 · Cited by 1

Rational use of corticosteroid treatment in the early phase of severe COVID-19

Ratanarat, R., & Thitayanapong, A. (2023) · Clinical Critical Care · doi:10.54205/ccc.v31.259411 · Cited by 1

Tissue location of SARS-CoV-2 RNA: A focus on bone and implications for skeletal health

Guazzoni, E., di Filippo, L., Castelli, A., Giustina, A., & Grassi, F. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18703-2.00016-5 · Cited by 1

The immunosuppressive role of neutrophils in infectious and oncological conditions: A study of chemokine receptor CXCR3 and human neutrophil lipocalin levels

Irakli, K., Kldiashvili, E., & Krajačić, M. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07229-9 · Cited by 1

COVID-19 and Pulmonary Embolism: Incidence and Pathophysiology

Rhoades, R., McLaughlin, C., & Kaatz, S. (2025) · Springer eBooks · doi:10.1007/978-3-030-70904-4_55-1 · Cited by 1

Síntomas Neurológicos por Covid-19, ¿en realidad son frecuentes?

Santos, C. A. M.-D. L., Manrique-Carmona, L. P., & Mejía-Mantilla, J. H. (2021) · Archivos de Neurociencias · doi:10.31157/archneurosciencesmex.v26i01.269 · Cited by 1

Revisiting Metchnikoff's work in light of the COVID-19 pandemic

Cavaillon, J., & Levin, J. (2022) · Innate Immunity · doi:10.1177/17534259211070663 · Cited by 1

Ключові ланки патогенезу легеневої недостатності при COVID-19 та шляхи фармакокорекції

Лук’янчук, В. Д., Гордійчук, Д. О., & Shevchuk, O. O. (2022) · Bulletin Of Medical And Biological Research · doi:10.11603/bmbr.2706-6290.2022.2.13082 · Cited by 1

Identification of Serum Prognostic Biomarkers of Severe COVID-19 by Quantitative Proteomic ApproachPreprint

Kimura, Y., Nakai, Y., Shin, J., Hara, M., Takeda, Y., Kubo, S., Jeremiah, S. S., Ino, Y., Akiyama, T. H., Moriyama, K., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-156575/v1 · Cited by 1

Overview of the Cytokine Assay Multiverse

Valencia, J. C., Nguyen, N. T. T., & Young, H. A. (2024) · Wiley eBooks · doi:10.1002/9781683674023.ch31 · Cited by 1

The Natural History of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Composite But Incomplete Picture

Sachithanandham, J., Thio, C. L., & Balagopal, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1413

Looking forward to a post-COVID era: A mentor's perspective

Agarwal, B. B., Agarwal, S., & Mital, K. (2020) · Indian Journal of Colo-Rectal Surgery · doi:10.4103/2666-0784.297114

Nurse adaptability: Implementing clinical trials in the midst of a pandemic

Mendez, S. J., Raimondo, B. J., & Hughes, P. (2020) · Journal of Nursing Education and Practice · doi:10.5430/jnep.v11n4p30

Cytokine inhibitors in COVID-19: looking back to move forward

Szakmány, T., & Duric, N. (2021) · Minerva Anestesiologica · doi:10.23736/s0375-9393.21.15837-7

Therapeutic potential of anticoagulant therapy in association with cytokine storm inhibition in severe cases of COVID-19: A case report

Xu, Q., Wang, T., & Lü, W. (2021) · Open Life Sciences · doi:10.1515/biol-2021-0088

Hiponatremia y lesión pulmonar: ¿una asociación peligrosa en SARS-CoV-2?

Cervantes, L. L., Díaz, J. S. S., Moguel, K. G. P., Zepeda, E. M., Escudero, E. A. G., & Sánchez, M. V. C. (2021) · Medicina Crítica · doi:10.35366/101154

COVID-19 and its Impact on the Management of Patients with Acute Coronary Syndrome during the First COVID Wave – A Questionnaire-Based Survey among Interventional Cardiologists from Southern India

Muralidharan, T. R., Kumar, B. V., Krishnamurthy, P., Senguttuvan, N. B., Balasubramaniyan, J. V., Sadhanandham, S., Rathinasamy, J., Sankaran, R., Panchanatham, M., Murthy, J. S. S., et al. (2021) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_43_21

Background

Sessa, M., Rizzi, M., & Gerevini, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-67521-9_2

Systemic Inflammation Alters the Neuroinflammatory Response: A Prospective Clinical Trial in Traumatic Brain Injury.Preprint

Lassarén, P., Lindblad, C., Frostell, A., Carpenter, K. L. H., Guilfoyle, M. R., Hutchinson, P., Helmy, A. E., & Thelin, E. P. (2021) · Research Square · doi:10.21203/rs.3.rs-345717/v1

Effectiveness and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisPreprint

Qu, W., Wang, Z., Engelberg-Cook, E., Siddik, A. B., Bu, G., Allickson, J. G., Kubrova, E., Caplan, A. I., Hare, J. M., Ricordi, C., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3924851

Outcome and Survival of Severe to Critical COVID-19 Patients Admitted at Zagazig University Hospitals

Mahmoudy, M. E.-S., Shouman, W., Mansor, A. M., & Ibrahim, D. A. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.235953

Precision medicine in COVID-19 patients

Tomo, S., Batra, J., & Aggarwal, J. (2022) · Santosh University Journal of Health Sciences · doi:10.4103/sujhs.sujhs_8_22

Role of Viral Storm in Critical COVID-19 Illness: A Prospective Cohort Multicentric StudyPreprint

Bermejo-Martín, J. F., García‐Mateo, N., Motos, A., Resino, S., Tamayo, L., Ryan, P., Bustamante‐Munguira, E., Curto, E. G., Úbeda, A., de la Torre, M. D. C., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4188788

Continuous renal replacement therapy using a cellulose triacetate hemofilter for severe coronavirus disease

Takahashi, K., Inoue, H., Kishimoto, M., Nakayama, R., Kasai, T., Bunya, N., Harada, K., Uemura, S., & Narimatsu, E. (2022) · Renal Replacement Therapy · doi:10.1186/s41100-022-00436-1

Cardiorenal Syndrome

Ronco, C., & Reis, T. D. A. (2022) · Nephrology Self-Assessment Program · doi:10.1681/nsap.2022.21.1.3

Polyunsaturated Fatty Acid-Derived Lipid Mediators as Biomarkers in Critical Care

Khan, B., O’Laughlin, A. E., Perelas, A., Thatcher, T. H., & Jackson, P. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-87302-8_77-1

Sepsis: Past, Present, and Future—Lessons Learned from COVID-19

Paiva, J.-A., & Rello, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88271-2.00006-7

The Effect of Vaccines and Booster Doses on Disease Progression and Mortality in Inpatients with COVID-19

Güzel, E., & Baydar, O. (2023) · Cukurova Anestezi ve Cerrahi Bilimler Dergisi · doi:10.36516/jocass.1242107

Adult sepsis as an emerging hospital-acquired infection: Challenges and solutions

Gandhi, P., & Shrivastava, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95388-7.00025-5

Hyponatremia: A marker of inflammation for COVID-19

Díaz, J. S. S., & Moguel, K. G. P. (2023) · Journal of Laboratory Physicians · doi:10.1055/s-0043-1773808

Immunological sub-phenotypes and response to Convalescent Plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial.Preprint

Misset, B., Diep, A. N., Bertrand, A., Piagnerelli, M., Hoste, E. A. J., Michaux, I., Waele, E. D., Dumoulin, A., Jorens, P. G., van der Hauwaert, E., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3793271/v1

COVID19 MORTALITY CORRELATION WITH THE BLOOD AND CYTOKINE LEVELS PARAMETERS IN 2021

Al-Saadi, Y. K. A., & Jrad, B. B. H. (2024) · The American Journal of Medical Sciences and Pharmaceutical Research · doi:10.37547/tajmspr/volume06issue01-08

Asociación entre disnatremias y mortalidad en pacientes con ventilación mecánica invasiva por SDRA secundario a COVID-19

García, J. L., Díaz, J. S. S., Moguel, K. G. P., González, E. C., Martínez, D. E., & Sánchez, M. V. C. (2023) · Medicina Crítica · doi:10.35366/114854

The Effects of Intravenous Diuretics on the use of Mechanical Ventilation on Covid 19 Patients requiring Supplemental Oxygen: A Propensity Score Matched Observational Study

Choi, K. J., Baccile, R., Soo, J., & Meltzer, D. O. (2024) · Journal of Surgery and Research · doi:10.26502/jsr.10020352

Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial

Misset, B., Diep, A. N., Bertrand, A., Piagnerelli, M., Hoste, E. A. J., Michaux, I., Waele, E. D., Dumoulin, A., Jorens, P. G., van der Hauwaert, E., et al. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01392-1

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

Leisman, D. E., Ronner, L., Pinotti, R., Taylor, M. D., Sinha, P., Calfee, C. S., Hirayama, A. V. V., Mastroianni, F., Turtle, C. J., Harhay, M. O., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30404-5 · Cited by 874

Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19

Vassiliou, A. G., Dimopoulou, I., Jahaj, E., Keskinidou, C., Mastora, Z., Orfanos, S. E., & Kotanidou, Α. (2021) · In Vivo · doi:10.21873/invivo.12381 · Cited by 4

Covid-19 and Cytokine Storm

Vergara, L. L., Torralba, L., Diego, C. D., Lasierra, A., Lahoz, R., Abadía, C., de Gopegui, P. R., Godino, J., Cebollada, A., Jimeno, B., et al. (2022) · 10.01 - Respiratory infections and bronchiectasis · doi:10.1183/13993003.congress-2022.3255

COVID 19: in the eye of the cytokine storm

Liuzzo, G., & Patrono, C. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1005 · Cited by 32

Drastically elevated levels of Interleukin-6 and its soluble receptor complex in COVID-19 patients with acute respiratory distress

Spigna, G. D., Cernia, D. S., Vargas, M., Buonavolontà, L., Servillo, G., & Postiglione, L. (2020) · Clinical and Medical Investigations · doi:10.15761/cmi.1000211 · Cited by 15